Enlivex Therapeutics Ltd Defensive Interval Ratio
Enlivex Therapeutics Ltd defensive interval ratio. Enlivex Therapeutics Ltd (ENLV) has a Defensive Interval Ratio of 1769 days as of September 2025. Defensive assets of ILA14.69 Million (cash ILA-, short-term investments ILA14.12 Million, receivables ILA567.00K) cover 1769 days of daily cash needs of ILA8.30K/day. Explore ENLV long-term investments to assets to see how much of total assets are deployed in long-term investments.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Defensive Interval Ratio of Enlivex Therapeutics Ltd (2012–2024)
Defensive interval ratio of Enlivex Therapeutics Ltd from 2012 to 2024. This chart shows how Enlivex Therapeutics Ltd's Defensive Interval Ratio has evolved across 13 annual periods from 2012 to 2024. As of September 2025, the ratio stands at 1769 days, meaning defensive assets of ILA14.69 Million can fund 1769 days of operations without new revenue. Read Enlivex Therapeutics Ltd (ENLV) total liabilities for a breakdown of total debt and financial obligations.
Enlivex Therapeutics Ltd Defensive Interval Ratio by Year (2012–2024)
Enlivex Therapeutics Ltd defensive interval ratio by year from 2012 to 2024. The table below presents the year-by-year Defensive Interval Ratio for Enlivex Therapeutics Ltd from 2012 to 2024, covering 13 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see Enlivex Therapeutics Ltd balance sheet assets.
| Year | DIR (days) | Defensive Assets (ILA) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 2076 days | ILA21.61 Million | ILA10.41K/day | ILA- | ILA20.20 Million | ▲ +466 days |
| 2023 | 1610 days | ILA26.74 Million | ILA16.61K/day | ILA- | ILA26.51 Million | ▲ +1558 days |
| 2022 | 52 days | ILA946.00K | ILA18.10K/day | ILA- | ILA299.00K | ▼ -5760 days |
| 2021 | 5812 days | ILA75.13 Million | ILA12.93K/day | ILA- | ILA72.93 Million | ▲ +3201 days |
| 2020 | 2611 days | ILA31.28 Million | ILA11.98K/day | ILA- | ILA30.03 Million | ▲ +1941 days |
| 2019 | 670 days | ILA10.97 Million | ILA16.38K/day | ILA- | ILA8.06 Million | ▲ +588 days |
| 2018 | 82 days | ILA253.00K | ILA3.10K/day | ILA- | ILA40.00K | ▲ +6 days |
| 2017 | 76 days | ILA96.00K | ILA1.26K/day | ILA- | ILA- | ▲ +66 days |
| 2016 | 10 days | ILA52.00K | ILA5.29K/day | ILA- | ILA- | ▼ -11 days |
| 2015 | 21 days | ILA145.00K | ILA6.89K/day | ILA- | ILA- | ▲ +6 days |
| 2014 | 15 days | ILA93.00K | ILA6.25K/day | ILA- | ILA- | ▼ -58 days |
| 2013 | 72 days | ILA26.00K | ILA358.90/day | ILA- | ILA- | ▲ +27 days |
| 2012 | 45 days | ILA10.00K | ILA221.92/day | ILA- | ILA- | — |